Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-08

Clinical Trial Update: Effect of New Oral Treatment for Hepatitis C Virus on Seminal Parameters [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating a new oral treatment for hepatitis C shows effects on seminal parameters in male participants with HCV-related infertility.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • New Oral Treatment for Hepatitis C Virus

Snippet

Sponsor: Benha University | Conditions: Male Infertility, HCV | Phase 2, Phase 3 | Status: COMPLETED